ANI Pharmaceuticals ANIP Stock
ANI Pharmaceuticals Price Chart
ANI Pharmaceuticals ANIP Financial and Trading Overview
| ANI Pharmaceuticals stock price | 71.44 USD |
| Previous Close | 71.06 USD |
| Open | 70.8 USD |
| Bid | 56.91 USD x 200 |
| Ask | 103.53 USD x 200 |
| Day's Range | 70.37 - 72 USD |
| 52 Week Range | 67.14 - 87.76 USD |
| Volume | 243.18K USD |
| Avg. Volume | 412.4K USD |
| Market Cap | 1.62B USD |
| Beta (5Y Monthly) | 0.466 |
| PE Ratio (TTM) | 14.118578 |
| EPS (TTM) | 5.06 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 103.38 USD |
ANIP Valuation Measures
| Enterprise Value | 1.69B USD |
| Trailing P/E | 14.118578 |
| Forward P/E | 7.001801 |
| PEG Ratio (5 yr expected) | 1.73 |
| Price/Sales (ttm) | 1.5593486 |
| Price/Book (mrq) | 2.3945034 |
| Enterprise Value/Revenue | 1.626 |
| Enterprise Value/EBITDA | 7.197 |
Trading Information
ANI Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.466 |
| 52-Week Change | -14.97% |
| S&P500 52-Week Change | 12.28% |
| 52 Week High | 87.76 USD |
| 52 Week Low | 67.14 USD |
| 50-Day Moving Average | 72.31 USD |
| 200-Day Moving Average | 77.01 USD |
ANIP Share Statistics
| Avg. Volume (3 month) | 412.4K USD |
| Avg. Daily Volume (10-Days) | 648.63K USD |
| Shares Outstanding | 22.72M |
| Float | 19.42M |
| Short Ratio | 10.88 |
| % Held by Insiders | 5.42% |
| % Held by Institutions | 109.51% |
| Shares Short | 3.58M |
| Short % of Float | 19.25% |
| Short % of Shares Outstanding | 15.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 11.21% |
| Operating Margin (ttm) | 14.65% |
| Gross Margin | 61.05% |
| EBITDA Margin | 22.59% |
Management Effectiveness
| Return on Assets (ttm) | 6.41% |
| Return on Equity (ttm) | 20.44% |
Income Statement
| Revenue (ttm) | 1.04B USD |
| Revenue Per Share (ttm) | 49.6 USD |
| Quarterly Revenue Growth (yoy) | 27.60% |
| Gross Profit (ttm) | 635.8M USD |
| EBITDA | 235.33M USD |
| Net Income Avi to Common (ttm) | 108.53M USD |
| Diluted EPS (ttm) | 5.06 |
| Quarterly Earnings Growth (yoy) | 32.10% |
Balance Sheet
| Total Cash (mrq) | 436.97M USD |
| Total Cash Per Share (mrq) | 20.63 USD |
| Total Debt (mrq) | 617.36M USD |
| Total Debt/Equity (mrq) | 96.9 USD |
| Current Ratio (mrq) | 2.746 |
| Book Value Per Share (mrq) | 29.835 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 229.2M USD |
| Levered Free Cash Flow (ttm) | 184.05M USD |
Profile of ANI Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Princeton |
| Address | 104 Carnegie Center Drive |
| ZIP | 08540 |
| Phone | 609 759 1810 |
| Website | https://www.anipharmaceuticals.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 970 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Princeton, New Jersey.
Q&A For ANI Pharmaceuticals Stock
What is a current ANIP stock price?
ANI Pharmaceuticals ANIP stock price today per share is 71.44 USD.
How to purchase ANI Pharmaceuticals stock?
You can buy ANIP shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ANI Pharmaceuticals?
The stock symbol or ticker of ANI Pharmaceuticals is ANIP.
Which industry does the ANI Pharmaceuticals company belong to?
The ANI Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does ANI Pharmaceuticals have in circulation?
The max supply of ANI Pharmaceuticals shares is 22.73M.
What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
ANI Pharmaceuticals PE Ratio is 14.11857800 now.
What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
ANI Pharmaceuticals EPS is 5.06 USD over the trailing 12 months.
Which sector does the ANI Pharmaceuticals company belong to?
The ANI Pharmaceuticals sector is Healthcare.
ANI Pharmaceuticals ANIP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31061.46 USD — |
-0.9
|
— — | 30735.41 USD — | 31415.87 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
7879.89 USD — |
-0.49
|
— — | 7812.06 USD — | 7910.07 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
1937.83 USD — |
-1.05
|
— — | 1915.46 USD — | 1955.74 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7211.27 USD — |
-0.5
|
— — | 7149.19 USD — | 7238.9 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
